Millipore (NYSE: MIL) is an innovative life science partner that propels our customers forward with the consumable products and services they need to confront challenging human health issues. Bringing our industry leadership and unparalleled scientific expertise, we engage in peer-to-peer discussions that advance the discovery, development, and production capabilities of leading academic, biotech and pharmaceutical customers. We ignite breakthrough innovations by collaborating with our customers in areas such as cell biology, protein research, and biopharmaceutical production. With more than 6,100 employees worldwide, Millipore is an S&P 500 company with operations in more than 47 countries.

More than 90 percent of the Millipore’s revenues come from consumable products and services. The Company is organized in two divisions: the Bioprocess Division, which represents approximately 60 percent of the Millipore’s revenues and Bioscience Division, which represents 40 percent. Millipore’s Bioprocess Division helps pharmaceutical and biotechnology companies to optimize their manufacturing productivity, ensure the quality of drugs, and scale up the production of difficult-to-manufacture biologics. The Company’s Bioscience Division helps optimize laboratory productivity and workflows by providing sample preparation, reagents, kits, services and other enabling technologies and products for life science research and development.